Comments
Loading...
Lexaria Bioscience (LEXX) Forecast
NewsEarningsLexaria Bioscience (LEXX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLexaria Bioscience (NASDAQ:LEXX) Stock Quotes, Forecast and News Summary
Lexaria Bioscience Stock (NASDAQ: LEXX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lexaria Bioscience (LEXX) stock?
You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.
Who are Lexaria Bioscience (LEXX) competitors?
Other companies in Lexaria Bioscience’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for Lexaria Bioscience (LEXX) stock?
Lexaria Bioscience has a consensus price target of $11.00.
What is the current price for Lexaria Bioscience (LEXX)?
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $2.15 last updated November 21, 2024 at 12:41 PM EST.
Does Lexaria Bioscience (LEXX) pay a dividend?
There are no upcoming dividends for Lexaria Bioscience.
When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?
Lexaria Bioscience’s Q1 earnings are confirmed for Friday, January 10, 2025.
Is Lexaria Bioscience (LEXX) going to split?
There is no upcoming split for Lexaria Bioscience.
What sector and industry does Lexaria Bioscience (LEXX) operate in?
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.